Les « HIV controllers » : un groupe homogène de patients infectés par le VIH avec un contrôle spontané de la réplication virale

Hogan, 2001, Host determinants in HIV infection and disease, Ann. Intern. Med., 134, 761, 10.7326/0003-4819-134-9_Part_1-200105010-00013 Migueles, 2000, HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proc. Natl. Acad. Sci. USA, 97, 2709, 10.1073/pnas.050567397 Cao, 1995, Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection, N. Engl. J. Med., 332, 201, 10.1056/NEJM199501263320401 Greenough, 1999, Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort, J. Infect. Dis., 180, 1790, 10.1086/315128 Migueles, 2002, HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors, Nat. Immunol., 3, 1061, 10.1038/ni845 Lefrere, 1997, Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of Human Immunodeficiency Virus infection, Blood, 90, 1133, 10.1182/blood.V90.3.1133 Strathdee, 1996, Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters, AIDS, 10, 959, 10.1097/00002030-199610090-00005 Flores-Villanueva, 2001, Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity, Proc. Natl. Acad. Sci. USA, 98, 5140, 10.1073/pnas.071548198 Rodes, 2004, Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection, AIDS, 18, 1109, 10.1097/00002030-200405210-00004 Madec, 2005, Meyer L for the SEROCO study group. Spontaneously controlled long-term viremia in HIV-1 seroconverters: an uncommon phenomenon?, Clin. Inf. Dis., 40, 1350, 10.1086/429318 Meyer, 1997, Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group, AIDS, 11, F73, 10.1097/00002030-199711000-00001 Rouzioux, 2005, Early levels of HIV-1 DNA in Peripheral Blood Mononuclear Cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ cell counts, J. Infect. Dis., 192, 10.1086/430610 Lacabaratz-Porret, 2003, Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection, J. Infect. Dis., 187, 748, 10.1086/368333 Dalod, 1999, Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy, J. Virol., 73, 7108, 10.1128/JVI.73.9.7108-7116.1999 Williams, 2004, Persistent GB virus C infection and survival in HIV-infected men, N. Engl. J. Med., 350, 981, 10.1056/NEJMoa030107 Lambotte, 2005, HIV controllers: a homogeneous group of HIV-1 infected patients with spontaneous control of viral replication, Clin. Inf. Dis., 41, 1053, 10.1086/433188 Trkola, 2004, HIV-host interactions: vital to the virus and key to its inhibition, Curr. Opin. Microbiol., 7, 407, 10.1016/j.mib.2004.06.002 Lacabaratz C, Saez-Cirion A, Lambotte O, et al. Anti-HIV-1 specific response and in vitro suppressive activity mediated by CD8+ T cells from HIV controllers. 13e Congress of Retroviruses and Opportunistic Infections, Denver, Février 2006, CA 298.